| Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis BA Johnson, X Xie, AL Bailey, B Kalveram, KG Lokugamage, A Muruato, ... Nature 591 (7849), 293-299, 2021 | 611 | 2021 |
| Furin cleavage site is key to SARS-CoV-2 pathogenesis BA Johnson, X Xie, B Kalveram, KG Lokugamage, A Muruato, J Zou, ... BioRxiv, 2020 | 180 | 2020 |
| Engineering SARS-CoV-2 using a reverse genetic system X Xie, KG Lokugamage, X Zhang, MN Vu, AE Muruato, VD Menachery, ... Nature protocols 16 (3), 1761-1784, 2021 | 142 | 2021 |
| Cutting edge: nucleocapsid vaccine elicits spike-independent SARS-CoV-2 protective immunity WE Matchett, V Joag, JM Stolley, FK Shepherd, CF Quarnstrom, ... The Journal of Immunology 207 (2), 376-379, 2021 | 138 | 2021 |
| Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis BA Johnson, Y Zhou, KG Lokugamage, MN Vu, N Bopp, ... PLoS pathogens 18 (6), e1010627, 2022 | 97 | 2022 |
| Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge A Muruato, MN Vu, BA Johnson, ME Davis-Gardner, A Vanderheiden, ... PLoS biology 19 (11), e3001284, 2021 | 59 | 2021 |
| Enterovirus persistence in cardiac cells of patients with idiopathic dilated cardiomyopathy is linked to 5’terminal genomic RNA-deleted viral populations with viral-encoded … A Bouin, PA Gretteau, M Wehbe, F Renois, Y N’guyen, N Lévêque, MN Vu, ... Circulation 139 (20), 2326-2338, 2019 | 59 | 2019 |
| Novel ionophores active against La Crosse virus identified through rapid antiviral screening ZJ Sandler, MR Firpo, OS Omoba, MN Vu, VD Menachery, BC Mounce Antimicrobial agents and chemotherapy 64 (6), 10.1128/aac. 00086-20, 2020 | 35 | 2020 |
| QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis MN Vu, KG Lokugamage, JA Plante, D Scharton, AO Bailey, S Sotcheff, ... Proceedings of the National Academy of Sciences 119 (32), e2205690119, 2022 | 29 | 2022 |
| SARS-CoV-2 uses nonstructural protein 16 to evade restriction by IFIT1 and IFIT3 C Schindewolf, K Lokugamage, MN Vu, BA Johnson, D Scharton, ... Journal of virology 97 (2), e01532-22, 2023 | 18 | 2023 |
| Binding and entering: COVID finds a new home MN Vu, VD Menachery PLoS pathogens 17 (8), e1009857, 2021 | 14 | 2021 |
| Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection MN Vu, RE Alvarado, DR Morris, KG Lokugamage, Y Zhou, AL Morgan, ... bioRxiv, 2023.04. 17.536926, 2023 | 8 | 2023 |
| Enterovirus-cardiomyocyte interactions: impact of terminally deleted genomic RNAs on viral and host functions A Bouin, MN Vu, A Al-Hakeem, GP Tran, JHC Nguyen, BL Semler Journal of Virology 97 (1), e01426-22, 2023 | 4 | 2023 |
| Spike Processing and Protease Usage Effects on SARS-CoV-2 Pathogenesis MN Vu | | 2023 |
| Positive‐strand RNA viruses—a Keystone Symposia report J Cable, MR Denison, M Kielian, WT Jackson, R Bartenschlager, T Ahola, ... Annals of the New York Academy of Sciences 1521 (1), 46-66, 2023 | | 2023 |
| Effects of viral 2A proteinase activity expressed by persistent forms of enterovirus RNAs harboring 5’terminal deletions A Bouin, M Vu, L Andreoletti, B Semler 38th annual meeting of the American Society for Virology, 2019 | | 2019 |
